These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8740632)

  • 1. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
    Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES
    Dementia; 1996; 7(3):169-74. PubMed ID: 8740632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
    Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
    Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
    Traykov L; Rigaud AS; Baudic S; Smagghe A; Boller F; Forette F
    J Neurol Sci; 2002 Nov; 203-204():177-81. PubMed ID: 12417380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.
    Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM
    Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.
    Martinoli MG; Trojanowski JQ; Schmidt ML; Arnold SE; Fujiwara TM; Lee VM; Hurtig H; Julien JP; Clark C
    Acta Neuropathol; 1995; 90(3):239-43. PubMed ID: 8525796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
    Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
    Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.
    Payami H; Grimslid H; Oken B; Camicioli R; Sexton G; Dame A; Howieson D; Kaye J
    Am J Hum Genet; 1997 Apr; 60(4):948-56. PubMed ID: 9106542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
    Yip AG; Brayne C; Easton D; Rubinsztein DC;
    J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease.
    Traykov L; Rigaud AS; Caputo L; Couderc R; Coste J; Michot JL; de Rotrou J; Amouyel P; Forette F; Boller F
    Eur J Neurol; 1999 Jul; 6(4):415-21. PubMed ID: 10362893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan.
    Nunomura A; Chiba S; Eto M; Saito M; Makino I; Miyagishi T
    Neurosci Lett; 1996 Mar; 206(1):17-20. PubMed ID: 8848271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
    Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
    Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.
    Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH
    Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease.
    Kurz A; Egensperger R; Haupt M; Lautenschlager N; Romero B; Graeber MB; Müller U
    Neurology; 1996 Aug; 47(2):440-3. PubMed ID: 8757017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.